![]() |
產(chǎn)地 | 進(jìn)口、國產(chǎn) |
品牌 | 上海莼試 |
保存條件 | Store at -20 °C |
貨號(hào) | CS11205 |
應(yīng)用范圍 | WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500 |
CAS編號(hào) | |
抗體名 | Anti-phospho-RelB(Ser551) |
克隆性 | |
靶點(diǎn) | 詳見說明書 |
適應(yīng)物種 | 詳見說明書 |
形態(tài) | 詳見說明書 |
宿主 | 詳見說明書 |
亞型 | IgG |
標(biāo)識(shí)物 | 詳見說明書 |
濃度 | 1mg/1ml% |
免疫原 | KLH conjugated Synthesised phosphopeptide derived from human RelB around the phosphorylation site of Ser551 |
技術(shù)外包服務(wù):
★磷酸化轉(zhuǎn)錄因子RelB蛋白抗體費(fèi)用 分子生物學(xué):質(zhì)粒抽提、PCR、Q-PCR、RT-PCR、分子生物學(xué):基因合成、引物合成、基因測序、載體構(gòu)建等
★蛋白工程:原核、哺乳動(dòng)物蛋白表達(dá)系統(tǒng)等
★病毒包裝:腺病毒、慢病毒等
★抗體工程:磁珠分選、病理染色、WB、ELISA、IP、IF、IHC、FACS、Confocal等等
★細(xì)胞工程:細(xì)胞表型分析(凋亡、增殖、周期、遷移、侵襲、修復(fù)、克隆形成)、細(xì)胞培養(yǎng)、細(xì)胞膜制備、穩(wěn)定細(xì)胞株構(gòu)建、細(xì)胞RNAi技術(shù)等等。
實(shí)驗(yàn)流程:
磷酸化轉(zhuǎn)錄因子RelB蛋白抗體費(fèi)用 英文名稱 Anti-phospho-RelB(Ser551)
中文名稱 磷酸化轉(zhuǎn)錄因子RelB蛋白抗體費(fèi)用
別 名 RELB (phospho S551); RelB (phospho Ser551); RelB (Ser551); I REL; IREL; Nuclear factor of kappa light polypeptide gene enhancer in B cells 3; RelB; Reticuloendotheliosis viral oncogene homolog B; Transcription factor RelB; v rel avian reticuloendotheliosis viral oncogene homolog; v rel reticuloendotheliosis viral oncogene homolog B; RELB_HUMAN; I-Rel.
產(chǎn)品屬性:
濃 度 1mg/1ml
規(guī) 格 0.1ml/100μg
抗體來源 Rabbit
克隆類型 polyclonal
交叉反應(yīng) Human, Mouse, Rat, Cow, Rabbit
產(chǎn)品類型 一抗 磷酸化抗體
研究領(lǐng)域 免疫學(xué) 信號(hào)轉(zhuǎn)導(dǎo) 轉(zhuǎn)錄調(diào)節(jié)因子
蛋白分子量 predicted molecular weight: 64kDa
性 狀 Lyophilized or Liquid
免 疫 原 KLH conjugated Synthesised phosphopeptide derived from human RelB around the phosphorylation site of Ser551
亞 型 IgG
純化方法 affinity purified by Protein A
儲(chǔ) 存 液 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide
磷酸化轉(zhuǎn)錄因子RelB蛋白抗體費(fèi)用 產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
(石蠟切片需做抗原修復(fù))
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
保存條件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
產(chǎn)品介紹 The NFKB complex consists of NFKB1 or NFKB2 bound to REL, RELA, or RELB. The NFKB complex is inhibited by I kappa B proteins (NFKBIA, or NFKBIB), which inactivate NF kappa B by trapping it in the cytoplasm. Phosphorylation of serine residues on the I kappa B proteins by kinases (IKBKA, or IKBKB,) marks them for destruction via the ubiquitination pathway, thereby allowing activation of the NF kappa B complex.
Function : NF-kappa-B is a pleiotropic transcription factor which is present in almost all cell types and is involved in many biological processed such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NF-kappa-B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-kappa-B complexes are held in the cytoplasm in an inactive state complexed with members of the NF-kappa-B inhibitor (I-kappa-B) family. In a conventional activation pathway, I-kappa-B is phosphorylated by I-kappa-B kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappa-B complex which translocates to the nucleus. NF-kappa-B heterodimeric RelB-p50 and RelB-p52 complexes are transcriptional activators. RELB neither associates with DNA nor with RELA/p65 or REL. Stimulates promoter activity in the presence of NFKB2/p49. As a member of the NUPR1/RELB/IER3 survival pathway, may provide pancreatic ductal adenocarcinoma with remarkable resistance to cell stress, such as starvation or gemcitabine treatment.
Subunit : Component of the NF-kappa-B RelB-p50 complex. Component of the NF-kappa-B RelB-p52 complex. Self-associates; the interaction seems to be transient and may prevent degradation allowing for heterodimer formation with p50 or p52. Interacts with NFKB1/p50, NFKB2/p52 and NFKB2/p100. Interacts with NFKBID.
Subcellular Location : Nucleus. Cytoplasm, cytoskeleton, centrosome. Note=Co-localizes with NEK6 in the centrosome.
Post-translational modifications : Phosphorylation at 'Thr-103' and 'Ser-573' is followed by proteasomal degradation.
Similarity : Contains 1 RHD (Rel-like) domain.
Database links : UniProtKB/Swiss-Prot: Q01201.2
全、新、優(yōu)、品、好四大特點(diǎn):
磷酸化轉(zhuǎn)錄因子RelB蛋白抗體費(fèi)用 全:公司提供上萬種產(chǎn)品,涵蓋了生物試劑,elisa試劑盒,標(biāo)準(zhǔn)品,培養(yǎng)基,原裝耗材,抗體、培養(yǎng)基、ATCC細(xì)胞等,基本上各種科研所需產(chǎn)品在我司都能找到。
新:產(chǎn)品更新速度較快,基本上每周都有新產(chǎn)品出現(xiàn)。
優(yōu):產(chǎn)品質(zhì)量好,投訴比較少。
好:我公司具有優(yōu)質(zhì)的技術(shù)團(tuán)隊(duì),產(chǎn)品一旦售出,實(shí)驗(yàn)過程中遇到困難可提供在線技術(shù)咨詢。使您使用產(chǎn)品時(shí)沒有任何的后顧之憂。
正在熱銷的相關(guān)產(chǎn)品:
NF2/merlin(neurofibromatosis type 2) 2型神經(jīng)抗原Multi-class antibodies規(guī)格: 0.5mg
Anti-APG4B/AUTL1 細(xì)胞自噬相關(guān)蛋白4B抗體Multi-class antibodies規(guī)格: 0.2ml
Rhesus antibody Rh Phospho-Aurora B(Thr232)/Aurora C(Thr198) 磷酸化有絲分裂激酶B/C抗體 規(guī)格 0.1ml
兔抗山羊 IgG(H+L)/Biotin 0.1ml 美國Jackson公司分裝
Vinculin 英文名稱: 粘著斑蛋白抗體 0.1ml
Desmoglein 4 英文名稱: 橋粒芯糖蛋白4抗體 0.1ml
Anti-APG4B/AUTL1 細(xì)胞自噬相關(guān)蛋白4B抗體Multi-class antibodies規(guī)格: 0.2ml
Anti-Omgp /FITC 熒光素標(biāo)記少突細(xì)胞髓磷脂糖蛋白抗體IgGMulti-class antibodies規(guī)格: 0.2ml
Rabbit Anti-human IgM/HRP 辣根過氧化物酶標(biāo)記兔抗人IgMMulti-class antibodies規(guī)格: 0.1ml
周期蛋白依賴激酶抑制因子1C抗體 Anti-Cdkn1c/p57/Kip2 0.2ml
Rabbit Anti-horse IgM/PE PE標(biāo)記的兔抗馬IgM 0.1ml
FASP1 英文名稱: MaFF相關(guān)蛋白抗體 0.2ml
Rhesus antibody Rh PLAGL2 多形性腺瘤基因樣蛋白2抗體 規(guī)格 0.2ml
Rabbit Anti-human IgM/HRP 辣根過氧化物酶標(biāo)記兔抗人IgMMulti-class antibodies規(guī)格: 0.1ml
SMYD4 英文名稱: 組蛋白甲基轉(zhuǎn)移酶SMYD4抗體 0.2ml
E cadherin 英文名稱: 上皮鈣粘附分子抗體 0.1ml
抗布魯氏菌抗體 Anti-Brucella 0.1ml
Anti-Tuberin/TSC2/FITC 熒光素標(biāo)記馬鈴薯球蛋白(性硬化)抗體IgGMulti-class antibodies規(guī)格: 0.2ml
Rhesus antibody Rh phospho-ICAM1(Tyr512) 磷酸化細(xì)胞間粘附分子1抗體 規(guī)格 0.1ml
Beta-catenin/ Beta-cats β-連環(huán)蛋白抗原(β-β鏈接素)Multi-class antibodies規(guī)格: 0.5mg
NIH/3T3, 小鼠成纖維細(xì)胞系
CCD-18Co 正常人組織細(xì)胞
FLT1 Others Human 人 FLT1 / VEGFR1 人細(xì)胞裂解液 (陽性對照)
CL-0062CHO-K1(倉鼠卵巢細(xì)胞亞株)5×106cells/瓶×2
比色法鈣分析試劑盒CCA
EB病毒轉(zhuǎn)化的人B淋巴細(xì)胞(傣族);KM9405 人大隱平滑肌細(xì)胞完全培養(yǎng)基 100mL
CL-0098HCT-8(人盲腸腺癌細(xì)胞)5×106cells/瓶×2
RSPO1 Others Human 人 R-Spondin 1 / RSPO1 CHO細(xì)胞裂解液 (陽性對照)
人小腦星形膠質(zhì)細(xì)胞裂解物HA-c L
新生牛眼Tenon's囊成纖維細(xì)胞;NBTF 腺癌細(xì)胞,RKO細(xì)胞 TA2細(xì)胞,小鼠自發(fā)高癌細(xì)胞
人原胚腎轉(zhuǎn)化細(xì)胞;293 Ad5
TIMP1 Others Mouse 小鼠 TIMP1 / TIMP / CLGI 人細(xì)胞裂解液 (陽性對照)
磷酸化轉(zhuǎn)錄因子RelB蛋白抗體費(fèi)用 NIH/3T3, 小鼠成纖維細(xì)胞系
CCD-18Co 正常人組織細(xì)胞
FLT1 Others Human 人 FLT1 / VEGFR1 人細(xì)胞裂解液 (陽性對照)
CL-0062CHO-K1(倉鼠卵巢細(xì)胞亞株)5×106cells/瓶×2
比色法鈣分析試劑盒CCA
EB病毒轉(zhuǎn)化的人B淋巴細(xì)胞(傣族);KM9405 人大隱平滑肌細(xì)胞完全培養(yǎng)基 100mL